News Briefing channel feed – Endpoints News

SIGN UP

News Briefing channel feed

Ophthalmic biotech raises $16.5M; Pfizer’s AI collaboration bears fruit

14 hours ago

Cerevance's $47M raise; Parexel's AI pact

Yesterday

Centessa's public offering; Vivoryon ends Ph2 Alzheimer’s trial

2 days ago

Brise raises $20M; Taro shareholder criticizes Sun Pharma deal

3 days ago

Ipsen, Skyhawk ink deal worth up to $1.8B; Hepion to wind down NASH trial

4 days ago

Histogen files for bankruptcy; Barinthus Bio shares Ph1b/2 data for HPV treatment

Last week

Biohaven’s $230M offering; Plus, three new PIPEs

Last week

Intra-Cellular aims to raise $500M; Lilly’s Prevail cuts three partnered programs

Last week

Takeda’s new deal with Kumquat; IL-2 biotech raises $55M

Last week

Mustang Bio to lay off workers; MaaT's new data for microbiome therapy

Last week

Nurix's $175M offering; Invivyd CEO is out

2 weeks ago

Century Therapeutics buys Clade; Eliem announces $120M PIPE and a deal

3 weeks ago

Skye Bioscience uplists; OncoX's licensing deal with ABVC BioPharma

3 weeks ago

Acrivon draws in $130M; Vincerx Pharma's Ph1 metastatic tumor data

3 weeks ago

LIB details Ph3 PCSK9 inhibitor data; Eyenovia seeks 'strategic alternatives'

3 weeks ago

Protara's $45M placement; Plus, news about Eupraxia and GenSight

3 weeks ago

Candel’s promising Ph2 data in pancreatic cancer; Microbiome biotech raises £27M

4 weeks ago

Ascletis Pharma scraps liver disease program; Another reverse merger

4 weeks ago

Zymeworks removes CFO; Gilead extends Nurix deal

4 weeks ago

Omega cuts 35% of workforce; Rhythm, CervoMed, Surrozen raise new funding

4 weeks ago

Bayer to cut 90 workers; Avalo's up to $185M private placement

5 weeks ago

Gamida Cell to go private; Stoke aims to raise $75M

5 weeks ago

Edgewood's $20M Series A; Nanoscope to pursue FDA approval for eye gene therapy later this year

Last month

Axsome clears Phase 3 in narcolepsy; Nkarta eyes $240M raise

Last month

12 3 4 Next page Last page